| Literature DB >> 24956166 |
Miao He1, Wei Wang1, Dina Ragoonundun1, Wenyong Huang1.
Abstract
BACKGROUNDS: Many studies have evaluated the association between lumican (LUM) gene polymorphisms and high myopia. However, the results remain controversial. This meta-analysis aims to comprehensively evaluate the relationship between two common LUM polymorphisms (rs3759223 and rs3759222) and the risk of high myopia.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24956166 PMCID: PMC4067286 DOI: 10.1371/journal.pone.0098748
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1literature search flow.
Characteristics of case-control studies included in the meta-analysis.
| First author (year) | Location | Source of control | Genotyping method | Definition of high myopia | Subjects (n) | Mean age(year) | HWE | NOS score | ||
| Case | Control | Case | Control | |||||||
| Park (2013) | Korea | PB | PCR-RFLP | ≤−9.25 D | 128 | 235 | 32.5 | 40.5 | Yes | 7 |
| Dai (2012) | Mainland of China | PB | PCR-SSP | ≤−10.00 D | 292 | 299 | NA | NA | Yes | 8 |
| Yip (2011) | Hong Kong | HB | PCR | ≤−8.00 D | 656 | 654 | NA | NA | Yes | 7 |
| Lin(a) (2009) | Taiwan | PB | PCR | ≤−6.50 D | 182 | 79 | 18 | 18 | Yes | 7 |
| Lin(b) (2009) | Taiwan | PB | PCR-RFLP, DS | ≤−6.00 D | 201 | 86 | 11 | 5 | No | 8 |
| Chen (2009) | Taiwan | HB | Sequencing | ≤−10.00 D | 120 | 137 | NA | NA | Yes | 8 |
| Zhang (2009) | Mainland of China | PB | PCR-DS | ≤−6.00 D | 94 | 90 | 37 | 36 | Yes | 8 |
| Wang (a) (2009) | Mainland of China | HB | PCR-RFLP | ≤−6.00 D | 288 | 208 | 21.76 | 27.32 | Yes | 7 |
| Wang (b) (2006) | Taiwan | HB | PCR-DS | ≤−10.00 D | 120 | 137 | 34.4 | 41.9 | Yes | 7 |
PB, population based; HB, hospital based; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; DS, direct sequencing; SSP, sequence-specific primer; D, diopter; NA, data not available; HWE, Hardy-Weinberg equilibrium in controls; NOS: Newcastle-Ottawa Scale.
Results of the Meta-analysis for rs3759223 and rs3759222 polymorphism and high myopia.
| Genotype contrast | Case | Control | OR | 95%CI | Overall Effect | Heterogeneity | |||
| estimate | L | U | Z | P | I2(%) | P | |||
| rs3759223 | |||||||||
| T vs C | 2706 | 2144 | 1.32 | 0.89 | 1.96 | 1.39 | 0.166 | 89.00 | 0.000 |
| TT vs CC | 793 | 553 | 1.74 | 0.71 | 4.26 | 1.20 | 0.229 | 85.30 | 0.000 |
| TC vs CC | 674 | 569 | 0.98 | 0.51 | 1.88 | 0.06 | 0.955 | 80.80 | 0.000 |
| (TT+TC) vs CC | 1233 | 936 | 1.21 | 0.59 | 2.52 | 0.52 | 0.604 | 86.10 | 0.000 |
| TT vs (CC+TC) | 1233 | 936 | 1.71 | 1.04 | 2.81 | 2.13 | 0.003 | 81.90 | 0.000 |
| rs3759222 | |||||||||
| A vs C | 1271 | 1535 | 1.13 | 0.96 | 1.32 | 0.85 | 0.133 | 0.00 | 0.855 |
| AA vs CC | 137 | 214 | 1.32 | 0.76 | 2.27 | 0.99 | 0.324 | 0.00 | 0.727 |
| AC vs CC | 404 | 531 | 1.13 | 0.80 | 1.59 | 0.68 | 0.495 | 0.00 | 0.337 |
| (AA+AC) vs CC | 248 | 372 | 1.17 | 0.84 | 1.62 | 0.93 | 0.353 | 0.00 | 0.368 |
| AA vs (CC+AC) | 248 | 372 | 1.27 | 0.76 | 2.11 | 0.90 | 0.371 | 0.00 | 0.953 |
Results of the subgroup analysis for rs3759223 polymorphism.
| Study group | T vs. C | T/T vs. C/C | T/C vs. C/C | T/T vs. T/C+C/C | T/T+T/C vs.C/C | |||||
| OR(95%CI) | P | OR(95%CI) | P | OR(95%CI) | P | OR(95%CI) | P | OR(95%CI) | P | |
|
| ||||||||||
|
| ||||||||||
| Mainland of China | 2.14(0.78–5.85) | 0.138 | 3.81(0.61–23.93) | 0.154 | 1.17(1.06–1.29) | 0.002 | 2.31(0.84–6.40) | 0.177 | 2.78(0.63–12.273) | 0.313 |
| Taiwan | 0.99(0.82–1.20) | 0.925 | 1.33(0.76–2.34) | 0.321 | 0.78(0.68–0.80) | <0.001 | 1.48(0.73–3.00) | 0.278 | 0.68(0.42–1.08) | 0.001 |
| Korea | 1.03(0.70–1.51) | 0.880 | 0.78(0.30–2.01) | 0.604 | 0.93(0.79–1.11) | 0.423 | 1.12(0.71–1.76) | 0.523 | 0.74(0.29–1.88) | 0.415 |
|
| ||||||||||
| PB | 1.48(0.74–2.95) | 0.273 | 1.47(0.74–2.95) | 0.438 | 0.99(0.91–1.09) | 0.871 | 1.84(0.91–3.71) | 0.090 | 1.27(0.41–3.92) | 0.679 |
| HB | 1.15(0.90–1.46) | 0.258 | 1.50(0.90–1.46) | 0.258 | 0.92(0.80–1.05) | 0.209 | 1.75(1.00–3.06) | 0.048 | 1.09(0.38–3.13) | 0.867 |
PB, population based; HB, hospital based; P, P value.
Results of the subgroup analysis for rs3759222 polymorphism.
| Study group | A vs. C | A/A vs. C/C | A/C vs. C/C | A/C vs. A/C+C/C | A/A+A/C vs. C/C | |||||
| OR(95%CI) | P | OR(95%CI) | P | OR(95%CI) | P | OR(95%CI) | P | OR(95%CI) | P | |
|
| ||||||||||
|
| ||||||||||
| Taiwan | 1.04(0.77–1.39) | 2.580 | 1.19(0.55–2.58) | 0.652 | 0.93(0.55–1.57) | 0.775 | 1.25(0.61–2.54) | 0.546 | 1.19(0.55–2.58) | 0.652 |
| Hong Kong | 1.13(0.90–1.41) | 0.294 | ||||||||
| Korea | 1.26(0.90–1.76) | 0.172 | 1.45(0.67–3.13) | 1.450 | 1.30(0.83–2.05) | 0.253 | 1.29(0.61–2.70) | 0.507 | 1.45(0.67–3.13) | 0.345 |
|
| ||||||||||
| PB | 1.26(0.90–1.76) | 0.172 | 1.45(0.67–3.13) | 0.345 | 1.16(0.91–1.48) | 0.245 | 1.29(0.61–2.70) | 0.507 | 1.33(0.86–2.05) | 0.197 |
| HB | 1.09(0.91–1.31) | 0.332 | 1.19(0.55–2.58) | 0.652 | 0.97(0.76–1.23) | 0.776 | 1.25(0.61–2.54) | 0.546 | 1.26(0.92–1.71) | 0.149 |
PB, population based; HB, hospital based; P, P value.